News

Filter results
E.g., 05/10/2022
E.g., 05/10/2022
15/02/2022
Risperidone ISM® is a prolonged-release injectable antipsychotic developed and patented by ROVI for the treatment of schizophrenia in adults for whom tolerability and effectiveness has been established with oral risperidone

Pages